Illumina strives to advance awareness of the importance of genetics and health. We recognize that education and clinical research are key to achieving this goal. We are dedicated to providing medical genetics education, supporting independent medical education, and investing in clinical studies. All these endeavors align with our core values and ethical responsibilities.
Illumina is committed to providing health care professionals with accurate, unbiased, and balanced information and education. Our education begins with basic genetic concepts and encompasses specific areas of focus including obstetrics, oncology, and rare diseases. This includes support for continuing medical education (CME) activities to help enhance health care providers' knowledge, with the goal of improving patient care.
This information is not a substitute for the exercise of the health care provider’s professional judgment in providing clinical services.
Find visual aids for patient discussions about reproductive genetic concepts, such as noninvasive prenatal testing (NIPT).Access PDF
Illumina is committed to the advancement of medicine and improvement of patient care by increasing awareness of the utility of genomics in medicine. We provide grants in support of accredited and non-accredited educational activities for health care providers and allied health professionals. Grant requests that align with our clinical areas of focus are given priority.
All grant proposals are reviewed for compliance with our policies and relevant legal and industry requirements, including guidelines set forth by the Accreditation Council for Continuing Medical Education (ACCME). Requests for an educational grant should be submitted at least 90 days prior to the proposed program date and/or accreditation date. Please submit requests to IMEDgrants@illumina.com.
Clinical trials are essential to our product development and clinical pipeline. We are committed to patient safety and value the importance of transparency. We are dedicated to sharing clinical trial information and data publicly. For more information about our involvement in clinical trials, visit clinicaltrials.gov.
We are currently seeking CME vendor proposals for enduring educational content for 2020. Proposals should explore actionable biomarkers across advanced disease, emerging biomarkers and signatures, comprehensive genomic testing, and where we are today with precision medicine in oncology. Send proposals to IMEDgrants@illumina.com by December 15, 2019 for consideration.